Konkurrenz
| Unternehmen | Börsenwert | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AbbVie NYSE:ABBV |
397,42 Mrd. | 2,49 % | 4/6 | 24,20 % | -38,10 % | 14,70 % | UP |
|
Amgen NasdaqGS:AMGN |
186,52 Mrd. | 7,37 % | 3/6 | 2,54 % | -7,20 % | 2,00 % | UP |
|
Gilead Sciences NasdaqGS:GILD |
160,39 Mrd. | 3,30 % | 5/6 | 4,06 % | -40,97 % | 23,86 % | UP |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
40,54 Mrd. | 46,06 % | 4/6 | 51,26 % | 16,14 % | 46,23 % | DOWN |
|
Alexion Pharmaceuticals NasdaqGM:ALXN |
40,34 Mrd. | 0,00 % | 4/4 | 0,00 % | 0,00 % | -100,00 % | UP |
|
Biogen NasdaqGS:BIIB |
29,00 Mrd. | -10,35 % | 1/6 | -1,92 % | 2,68 % | 9,44 % | UP |
|
Incyte NasdaqGS:INCY |
20,23 Mrd. | 41,79 % | 5/6 | 8,74 % | 23,23 % | 2,73 % | UP |
|
BioMarin Pharmaceutical NasdaqGS:BMRN |
10,92 Mrd. | 12,22 % | 5/6 | 39,07 % | 60,28 % | 52,29 % | DOWN |
|
Arrowhead Pharmaceuticals NasdaqGS:ARWR |
10,59 Mrd. | 48,13 % | 5/6 | -46,46 % | -7,86 % | 21,74 % | UP |
|
Blueprint Medicines NasdaqGS:BPMC |
8,38 Mrd. | 45,26 % | 4/6 | 42,18 % | -48,48 % | 0,64 % | UP |
|
Cidara Therapeutics NasdaqCM:CDTX |
6,97 Mrd. | -59,17 % | 2/6 | 0,00 % | -652349,57 % | -100,00 % | UP |
|
Arena Pharmaceuticals NasdaqGM:ARNA |
6,17 Mrd. | 0,00 % | 0,00 % | 0,00 % | 0,00 % | UP | |
|
Amicus Therapeutics NasdaqGM:FOLD |
4,55 Mrd. | 80,90 % | 5/6 | 32,54 % | -43,60 % | 0,07 % | UP |
|
Travere Therapeutics NasdaqGM:TVTX |
4,29 Mrd. | 10,07 % | 5/6 | 42,48 % | -116,48 % | 18,02 % | UP |
|
Catalyst Pharmaceuticals NasdaqCM:CPRX |
3,83 Mrd. | 40,95 % | 5/6 | 5,88 % | 4,85 % | 2,27 % | UP |
|
ChemoCentryx NasdaqGS:CCXI |
3,74 Mrd. | 0,00 % | 0/4 | 0,00 % | 0,00 % | -100,00 % | UP |
|
CymaBay Therapeutics NasdaqGS:CBAY |
3,72 Mrd. | 0,00 % | 1/4 | 0,00 % | 0,00 % | -100,00 % | UP |
|
ACADIA Pharmaceuticals NasdaqGS:ACAD |
3,72 Mrd. | 30,23 % | 5/6 | 14,58 % | -20,94 % | 47,33 % | DOWN |
|
Viking Therapeutics NasdaqCM:VKTX |
3,46 Mrd. | 0,00 % | 0/4 | 0,00 % | 0,00 % | 227,40 % | DOWN |
|
Celldex Therapeutics NasdaqCM:CLDX |
2,35 Mrd. | -34,10 % | 1/6 | 71,79 % | -361,67 % | 93,79 % | UP |
